Health · VanEck · NASDAQ
| Assets under management | $1.03B |
|---|---|
| Expense ratio | 0.36% |
| Category | Health |
| Dividend yield | 1.92% |
| NAV | $111.20 |
| Fund family | VanEck |
| Exchange | NASDAQ |
The largest positions VanEck Pharmaceutical ETF reports, by weight.
| Ticker | Fund | Assets | Expense |
|---|---|---|---|
| XLV | State Street Health Care Select Sector SPDR ETF | $43.91B | 0.08% |
| VHT | Vanguard Health Care Index Fund ETF Shares | $22.04B | 0.09% |
| XBI | State Street SPDR S&P Biotech ETF | $11.40B | 0.35% |
| IBB | iShares Biotechnology ETF | $10.47B | 0.44% |
| IXJ | iShares Global Healthcare ETF | $4.28B | 0.38% |
| IYH | iShares U.S. Healthcare ETF | $3.86B | 0.37% |
| FHLC | Fidelity MSCI Health Care Index ETF | $3.48B | 0.08% |
| IHI | iShares U.S. Medical Devices ETF | $3.47B | 0.37% |